Anwesha Dey is a Senior Director and Distinguished Scientist in the Discovery Oncology Department at Genentech. Prior to this position, she held postdoctoral research fellowships in the laboratory of Vishva Dixit at Genentech and at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in the laboratory of Sir David Lane. She obtained her PhD in the laboratory of Dr. Michael Summers at the Howard Hughes Medical Institute at UMBC, Maryland. Her scientific research at Genentech is focused on understanding the biology of Hippo and PI3K signaling pathways and how they can be targeted for cancer therapy. She has led drug discovery programs at Genentech and research from her lab has provided the foundation for developing first and best in class targets for therapeutic intervention. Dr. Dey has served as the co-chair of the AACR and FASEB meetings on the Hippo pathway — leading scientific meetings in the field. She serves on the Scientific Advisory Board (SAB) of the Keystone Symposia and is a recipient of the 2022 Genentech Women’s professional Emerging Leader Award, 2023 Changemaker of the year award at Genentech and 2023 Distinguished Alumni award recipient from University of Maryland. She is passionate about mentorship, Diversity, Equity, & Inclusion and a significant contributor to Genentech’s efforts in this area.